[ad_1]
And mention: "We do not know at the moment if our vaccine could also provide protection against this new type. But since the proteins in the new strain are 99 percent, which is the same percentage in the dominant strains, Biontech has scientific confidence in the vaccine.".
Shaheen indicated that Biontech is currently conducting further studies and hopes to confirm this in the coming weeks.
He stated: "The probability of success of our vaccine is relatively high".
And the Biontech vaccine, which was developed with the American pharmaceutical company "Pfizer"It is approved for use in more than 45 countries, including Great Britain, the United States, and the European Union.
“>
Shaheen said: “We are technically capable of producing a new vaccine in 6 weeks.”
He added at a press conference in Mainz, western Germany, the day after European authorities gave the green light to distribute the vaccine in the European Union.
He explained that the German pharmaceutical company is confident that its Corona virus vaccine will be effective against the new strain that appeared in Britain, but more studies are needed to be completely sure.
He said: “We don’t know at this time if our vaccine can also provide protection against this new type. But since the proteins in the new strain are 99 percent, which is the same percentage in the dominant strains, Biontech has scientific confidence in the vaccine”.
Shaheen indicated that Biontech is currently conducting further studies and hopes to confirm this in the coming weeks.
“The probability that our vaccine will be successful is relatively high,” he said.
The Biontech vaccine, which was developed with the US pharmaceutical company “Pfizer”, is approved for use in more than 45 countries, including Great Britain, the United States and countries of the European Union.
[ad_2]
